AsymBio secures US$184m capital injection
August 05, 2026 | 14:53
AsymBio, a biologics CDMO and subsidiary of Asymchem Group, secured a total capital injection of RMB 1.2397 billion, approximately US$184 million, to support its long-term growth plans.
Mobile Version